Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

NCOA ONCOLOGY DRUG NEWSLETTER J A N U A R Y 2 0 2 4 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Pirtobrutinib (Jaypirca) The FDA has approved pirtobrutinib (Jaypirca) in relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma …
TxSCO ONCOLOGY DRUG NEWSLETTER J A N U A R Y 2 0 2 4 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Pirtobrutinib (Jaypirca) The FDA has approved pirtobrutinib (Jaypirca) in relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma …
ASCO-ACCC Recommendations Increasing Racial & Ethnic Diversity in Cancer Clinical Trials The American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) jointly released recommendations to engage the entire cancer clinical trial ecosystem in expanding the participation of underrepresented individuals in research that advances progress against cancer …
Northwest Medical Specialties delivers proactive, comprehensive care using AI tool Background Northwest Medical Specialties (NWMS), located in the area of Tacoma, Wash., is a 6-site practice dedicated to providing compassionate, high quality and cost-effective medical services to patients with serious infections, malignancies and immune disorders. NWMS’s innovative approach to treatment …
JA13-Action
PRESENTED BY: Ambulatory 5FU infusion pumps: Patient perceptions and quality of life Munaf Alkadimi, MD Fellow UTHSCSA 1 PRESENTED BY: Disclosure of Conflicts of Interest Munaf Alkadimi, MD, has no relevant financial relationships to disclose. RESEARCH POSTER PRESENTATION DESIGN © 2015 www.PosterPresentations.com Ambulatory 5FU infusion pumps: Patient …
SO08-Action
FAN-Its-All-in-How-You-Phrase-It
ND08-CALGB-140503-A-Randomized-Phase-III-Trial-of-Lobectomy-versus-Sublobar-Resection-for-Small-Peripheral-Non-Small-Cell-Lung-Cancer
About the award An important part of the Rocky Mountain Oncology Society's mission is to demonstrate a strong commitment to supporting the educational needs of allied health professionals, including advanced practice providers, nurse practioners, and pharmacists, who are vital to the delivery of high-quality patient care across Colorado. To this end, we are pleased to present the new RMOS Allied …
« 1 2 3 4 5 » Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) Columbus, OH Expediting Cancer Treatment Through a Rapid Access APP-Led Diagnostic Clinic In response to data that showed a significant decrease in both the volume of cancer screening tests and the number of cancer diagnoses, the James Cancer Diagnostic Center …
The goal of treatment for most patients with myelofibrosis is to relieve symptoms. Hear Dr. Gerds discuss standard of care treatment options and new therapies for treating patients with myelofibrosis.
Oncology Icons is an award program created by Targeted Oncology™ that highlights the exceptional work of community oncologists. A quarterly Oncology Icons article is published on the Targeted Oncology™ website and in Targeted Therapies in Oncology™. In addition to being featured in a quarterly article, honorees are offered several opportunities to share their unique expertise with the oncology …
ACCC Innovator Awards Since 2011, ACCC Innovator Awards honor Cancer Program Members for their ingenuity and pioneering achievements in oncology. Innovations advance the goals of improving access, quality, and value in cancer care delivery. 2019 Winners 2018 Winners 2017 Winners 2016 Winners 2015 Winners 2014 Winners 2013 Winners 2012 Winners 2011 Winners
In this episode, we focus on the mental and emotional toll that COVID-19 continues to have on cancer care professionals—while much of the public experiences a “summer of joy” due to rising vaccinations.
As the COVID-19 pandemic recedes and restrictions loosens for most of the U.S., we'll discuss how patient education has become even more critical during this transition.
As a genitourinary medical oncologist specializing in immunotherapy for kidney and bladder cancers, I am continually striving for more ways to connect with and learn from my patients. The emerging availability of immuno-oncology (IO) drugs for the conditions I treat, as well as many other cancer types, has generated tremendous excitement amongst patients and oncologists, but there still is so much …
Envision a day that cancer clinicians can ask an app to advise on immuno-oncology (IO) treatment options for a patient. That day may not be far off. Big data, deep analytics, and predictive modeling methods are transforming how cancer clinicians weigh treatment options.
The ACCC Model for Improving Care Coordination has been transformed into a free, interactive online tool to evaluate the current state of care coordination for lung cancer patients at your cancer program or practice, and to help identify focus areas for improvement and next steps. Take action to improve care coordination: Take the FREE, online assessment to identify 12 areas in which your program …
CANCER BUZZ spoke to Robin Atkins, RN, OCN, symptom triage nurse, Virginia Oncology Associates in Norfolk, Virginia. Listen as we discuss effective practices to support patients with diffuse large b-cell lymphoma throughout the care continuum.